Total sample size 500 patients
Cost per patient per month $5,000
Planned trial duration 36 months
Enrollment through to primary readout
Enrollment period 18 months
Expected time saved — —
Expected marginal costs saved — —
Patients spared — Fewer patients exposed to ineffective or unnecessary treatment
Revenue acceleration — At ~$500K/day cost-of-delay (Getz 2024)
Timeline comparison
Without BRAKES —
Enrollment → Follow-up → Unblind
With BRAKES —
Continuous monitoring → Early decision
—

See what BRAKES would do for your trial

Send us your draft protocol and we'll run a full simulation,
custom-configured to your endpoints, population, and design.